December 2007 — Savient Pharmaceuticals, located in East Brunswick, New Jersey, has selected R&D Logic software for corporate planning, collecting and tracking, and financial reporting. Savient Pharmaceuticals is a specialty biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

December 2007 — Tercica, Inc., located in Brisbane, California, has chosen R&D Logic software for corporate planning, collecting and tracking, and financial reporting. Tercica is a biopharmaceutical company working to develop and commercialize therapeutics for growth and other endocrine disorders.

October 2007 — Catalyst Biosciences, located in South San Francisco, California, has opted to use R&D Logic software for time collection efforts, while planning and tracking project resources. Catalyst Biosciences is a leading biotechnology company focused on developing proteases as a therapeutic platform for inflammation, cardiovascular, and angiogenesis-based disorders.

August 2007 — Via Pharmaceuticals, Inc., located in San Francisco, California, has selected R&D Logic enterprise software for financial planning and analysis, consolidated reporting as well as for project time collection and project portfolio specific planning and tracking. VIA is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease.

June 2007 — Kalypsys, Inc., located in San Diego, California, has chosen R&D Logic software for tracking and planning project resources and time effort. Kalypsys is a clinical stage pharmaceutical company that is advancing the way drugs are discovered and developing breakthrough therapies for some of the world's most widespread diseases including cardiovascular/metabolic diseases, pain/inflammation and oncology.